Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mohit Angolkar"'
Autor:
Asha Spandana K M, Mohit Angolkar, Mohamed Rahamathulla, Kamal Y. Thajudeen, Mohammed Muqtader Ahmed, Syeda Ayesha Farhana, Thippeswamy Boreddy Shivanandappa, Sharanya Paramshetti, Riyaz Ali M. Osmani, Jawahar Natarajan
Publikováno v:
Pharmaceuticals, Vol 17, Iss 6, p 720 (2024)
Bromocriptine (BCR) presents poor bioavailability when administered orally because of its low solubility and prolonged first-pass metabolism. This poses a significant challenge in its utilization as an effective treatment for managing Parkinson’s d
Externí odkaz:
https://doaj.org/article/cc8e72ea24264222a6b0b1fdd3cc1028
Autor:
Sharanya Paramshetti, Mohit Angolkar, Adel Al Fatease, Sultan M. Alshahrani, Umme Hani, Ankitha Garg, Gundawar Ravi, Riyaz Ali M. Osmani
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1204 (2023)
The first conductive polymers (CPs) were developed during the 1970s as a unique class of organic substances with properties that are electrically and optically comparable to those of inorganic semiconductors and metals while also exhibiting the desir
Externí odkaz:
https://doaj.org/article/e4511f922367400dbc9ab152f5d4857f
Autor:
Mohit Angolkar, Sharanya Paramshetti, Praveen Halagali, Vikas Jain, Amit B Patil, Preethi Somanna
Publikováno v:
Therapeutic Delivery. 13:531-557
Nanotechnological advancements over the past few years have led to the development of newer treatment strategies in brain cancer therapy which leads to the establishment of nano oncology. Nanostructures with high specificity, are best suitable to pen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::571e80b3eb08db553516be32ce26f6c8
https://doi.org/10.4155/tde-2022-0035
https://doi.org/10.4155/tde-2022-0035